Fax: (919) 541-1275
A review and characterization of the various perceptions of quality cancer care
Article first published online: 11 OCT 2010
Copyright © 2010 American Cancer Society
Volume 117, Issue 5, pages 884–896, 1 March 2011
How to Cite
Colosia, A. D., Peltz, G., Pohl, G., Liu, E., Copley-Merriman, K., Khan, S. and Kaye, J. A. (2011), A review and characterization of the various perceptions of quality cancer care. Cancer, 117: 884–896. doi: 10.1002/cncr.25644
Fax: (919) 541-1275
- Issue published online: 18 FEB 2011
- Article first published online: 11 OCT 2010
- Manuscript Accepted: 12 AUG 2010
- Manuscript Received: 27 JUL 2010
- Unknown funding agency
- quality of healthcare;
- quality indicators;
- quality assurance;
- neoplasms/drug therapy;
- cancer care facilities;
- hospital oncology service
It is important to maintain high-quality cancer care while reducing spending. This requires an understanding of how stakeholders define “quality.” The objective of this literature review was to understand the perceptions patients, physicians, and managed care professionals have about quality cancer care, especially chemotherapy.
A computerized literature search was conducted for articles concerning quality cancer care in patients who received chemotherapy. Among >1100 identified sources, 25 presented interviews/survey results from stakeholders.
Patients defined quality cancer care as being treated well by providers, having multiple treatment options, and being part of the decision-making process. Waiting to see providers, having problems with referrals, going to different locations for treatment, experiencing billing inaccuracies, and navigating managed care reimbursement negatively affected patients' quality-of-care perceptions. Providers perceived quality cancer care as making decisions based on the risks-benefits of specific chemotherapy regimens and patients' health status rather than costs. Providers objected to spending substantial time interacting with payers instead of delivering care to patients. Payers must control the costs of cancer care but do not want an adversarial relationship with providers and patients. Payers' methods of managing cancer more efficiently involved working with providers to develop assessment and decision-assist tools.
Delivering quality cancer care is increasingly difficult because of the shortage of oncologists and rising costs of chemotherapy agents, radiation therapy, and imaging tests. The definition of quality cancer care differed among stakeholders, and healthcare reform must reflect these various needs to maintain and improve quality while controlling costs. Cancer 2011. © 2010 American Cancer Society